Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.

MLA

Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1378517553&authtype=sso&custid=ns315887.

APA

Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability. (2020).

Chicago

“Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.” 2020. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1378517553&authtype=sso&custid=ns315887.